HSE Researchers Contribute to Artificial Intelligence Journey Conference
The AI Journey international conference is a major platform for sharing cutting-edge innovations in artificial intelligence and machine learning. In late November 2022, AIJ was once again hosted by Sber. The conference was attended by HSE researchers from the Faculty of Computer Science and the Centre for Artificial Intelligence.
Meta-analysis Links Benevolent Sexism to Violence against Women
HSE researchers Elena Agadullina, Andrey Lovakov, Maryana Balezina and Olga Gulevich examined the potential links between different types of sexism – hostile and benevolent – and the likelihood of supporting or practicing violence against women. The authors conducted a meta-analysis of academic literature to find out how sexist attitudes can contribute to violence.
Research that Will Help Fight Corruption
Emmanuel Adu Sarfo, 23, from Ghana, is a second-year master's student on the HSE Economics and Economic Policy programme. He is carrying out research on the ancient roots of corruption that influence its prevalence in different countries. Emmanuel talked to the HSE News Service about his studies and research at HSE University in Moscow.
Only Left Hemisphere Involved in Action Naming
An international team including researchers from the HSE Centre for Language and Brain and the HSE Institute for Cognitive Neuroscience have demonstrated the critical role of the left, but not the right, inferior frontal gyrus in action naming. The study findings are published in Brain Structure and Function.
‘An STI-Accelerated and Informed Future is Possible’
The Twelfth International Academic Conference ‘Foresight and Science, Technology and Innovation Policy’ is kicking off at HSE University on November 22. Alexander Sokolov, chair of the organising committee, talked to the HSE News Service about the evolution of the foresight agenda. Two of the conference speakers, Ibon Zugasti from Spain and Mlungisi Cele from South Africa, shared some highlights of their research.
Optimism Makes Algorithm for Reinforcement Learning More Effective
An international team of scientists from Russia, France and Germany (including researchers of the HSE Faculty of Computer Science, the HSE Artificial Intelligence Centre and the Artificial Intelligence Research Institute) have developed a new reinforcement learning algorithm (Bayes-UCBVI). This is the first Bayesian algorithm that has a mathematical proof of effectiveness and has been successfully tested in Atari games. The result was presented at the ICML-2022 conference.
Research Finds Genes Associated with Most Aggressive Kidney Cancer
HSE researchers have found genes characteristic of the most aggressive subtype of clear cell renal carcinoma. Having studied data on tumour samples from 456 patients, Grigory Puzanov, research fellow at the HSE Faculty of Computer Science International Laboratory of Bioinformatics, identified cancer subtypes associated with either a favourable or unfavourable course of the disease. The paper is published in Scientific Reports.
17 Articles by Researchers of HSE Faculty of Computer Science Accepted at NeurIPS
In 2022, 17 articles by the researchers of HSE Faculty of Computer Science were accepted at the NeurIPS (Conference and Workshop on Neural Information Processing Systems), one of the world’s most prestigious events in the field of machine learning and artificial intelligence. The 36th conference will be held in a hybrid format from November 28th to December 9th in New Orleans (USA).
Study Explains Blood Donation Motivations
An international team of researchers from the HSE International Laboratory of Positive Psychology of Personality and Motivation, the Russian National Research Centre for Hematology, and a number of American universities examined the motivations of regular blood donors.
Microfluidic Chip Used to Test Drug Toxicity
A team including HSE researchers has developed a way to use microfluidic chips to assess the toxic effects of drugs on humans. This device will help identify and minimise the side effects of drugs during the preclinical trial stage and reduce the need for animal experiments. The study is published in Bulletin of Experimental Biology and Medicine.